Justice Department records released this year show Jeffrey Epstein quietly deposited sperm with California Cryobank years before his 2019 death, then signed a storage deal that would hand control of the material to his estate if he died. The newly public documents, part of the federal government’s massive Epstein-file dump, leave one very basic question hanging in the air: where are those samples now, and who, if anyone, could legally call the shots on using them?
CooperCompanies, the medical group that now owns California Cryobank, says it does not currently have any Epstein-linked samples on ice. Yet the files do not clearly account for what happened to any vials that may have existed, or whether they were moved, destroyed, or withdrawn before ownership of the business changed hands.
According to The New York Times, emails and internal forms in the Justice Department cache indicate Epstein deposited specimens sometime before October 2012, then signed a fresh specimen-storage contract on May 9, 2016. That agreement stated the samples remained his property and, if he died, would pass under the control of his estate or another legal representative. The wording set the arrangement apart from a typical donor agreement and suggested Epstein wanted the material preserved rather than automatically destroyed upon his death.
Per the Department of Justice, the trove released under the Epstein Files Transparency Act includes emails, medical records, contracts and other files that reporters and researchers have been combing through to reconstruct his activities and financial arrangements. Those searchable documents supplied the contract text and renewal notices that first tipped off legal researchers to the sperm banking setup.
CooperCompanies, which picked up the California Cryobank operation in a larger reproductive-services acquisition in 2021, told The New York Times that the bank "does not currently store any samples associated with Jeffrey Epstein" and declined to elaborate. The public records include email threads about renewal notices and a signed storage contract, but they do not say whether any vials survived the business transfer or were removed at some earlier point.
Legal and ethical tangle
Bioethicists and reproductive-law experts say the documents drag an uncomfortable set of questions back into the spotlight: should fertility clinics agree to store genetic material from convicted sex offenders, and who should decide whether that material is ever used? Kimberly Mutcherson, a Rutgers Law School professor who focuses on reproductive technology and bioethics, notes the field is already wrestling with how far clinics should go in screening people based on character or criminal history.
Some specialists warn that broad character-based bans could slide into discriminatory gatekeeping that locks out whole groups of patients rather than targeting specific harms. KFF Health News has summarized that debate after reviewing the Epstein-related records and the coverage surrounding them.
Who would have a claim?
If the 2016 contract truly vested ownership of the samples in Epstein rather than the bank, legal control would likely flow to the estate’s co-executors or whoever they designate. Any fight over that control would drop straight into the already tangled probate and trust proceedings tied to Epstein’s fortune.
His will and associated trusts have been handled in the U.S. Virgin Islands, which has been at the center of lawsuits and settlement talks over the estate. Earlier reporting on the probate structure has highlighted those USVI filings and the disputes around them. The Guardian covered the estate’s early probate moves and the role of the co-executors after Epstein’s death.
For now, the records add yet another procedural and moral knot to a case already packed with lawsuits and survivors’ settlements. The documents confirm that Epstein took concrete steps to preserve his genetic material, but they stop short of tracking any physical samples to their current location. What happens next will depend on whether any vials can be found, what the estate’s administrators decide, and whether a court is asked to rule on who, if anyone, can claim a say over their use.
